Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Baxter International Inc. before investing.

In this article, we go over a few key elements for understanding Baxter International Inc.’s stock price such as:

• Baxter International Inc.’s current stock price and volume
• Why Baxter International Inc.’s stock price changed recently
• Upgrades and downgrades for BAX from analysts
• BAX’s stock price momentum as measured by its relative strength

About Baxter International Inc. (BAX)

Before we jump into Baxter International Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors’ offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Want to learn more about Baxter International Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Baxter International Inc..

Baxter International Inc.’s Stock Price as of Market Close

As of April 29, 2026, 4:00 PM, CST, Baxter International Inc.’s stock price was $16.900.

Baxter International Inc. is down 5.8% from its previous closing price of $17.940.

During the last market session, Baxter International Inc.’s stock traded between $16.830 and $17.820. Currently, there are approximately 514.00 million shares outstanding for Baxter International Inc..

Baxter International Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Baxter International Inc. Stock Price History

Baxter International Inc.’s (BAX) price is currently up 0.6% so far this month.

During the month of April, Baxter International Inc.’s stock price has reached a high of $19.190 and a low of $16.310.

Over the last year, Baxter International Inc. has hit prices as high as $32.680 and as low as $15.730. Year to date, Baxter International Inc.’s stock is down 11.56%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Baxter International Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of April 29, 2026, there were 0 analysts who downgraded Baxter International Inc.’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate Baxter International Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Baxter International Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Baxter International Inc.’s current valuation based on AAII’s Value Grade is a B, which means it is considered to be Value.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Baxter International Inc. (BAX) by visiting AAII Stock Evaluator.

Relative Price Strength of Baxter International Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of April 29, 2026, Baxter International Inc. has a weighted four-quarter relative price strength of -18.60%, which translates to a Momentum Score of 12 and is considered to be Very Weak.

Want to learn more about how Baxter International Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Baxter International Inc. Stock Price: Bottom Line

As of April 29, 2026, Baxter International Inc.’s stock price is $16.900, which is down 5.8% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Baxter International Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.